1. Dihydroartemisinin Increases the Sensitivity of Acute Myeloid Leukemia Cells to Cytarabine via the Nrf2/HO-1 Anti-Oxidant Signaling Pathway
   Qiong Su et al, 2023, International Journal of Pharmacology CrossRef